

Compact for Safe Cosmetics
|
Animal Testing Policy |


Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to one or more ingredients in this product -- not the product itself -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
Ingredients in this product are linked to: | |
![]() | Cancer |
![]() | Developmental/reproductive toxicity |
![]() | Violations, restrictions & warnings |
![]() | Allergies/immunotoxicity |
![]() | Other concerns for ingredients used in this product: Neurotoxicity, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Enhanced skin absorption, Occupational hazards, Biochemical or cellular level changes |
Ingredients from packaging: ACTIVE INGREDIENT- HYDROQUINONE 2%, OTHER INGREDIENTS- WATER (AQUA), ALCOHOL DENAT., GLYCOLIC ACID, PROPYLENE GLYCOL, POLYQUATERNIUM-10, AMMONIUM HYDROXIDE, CITRIC ACID, SODIUM BISULFITE, SODIUM SULFITE, TRISODIUM EDTA, BHT.
Directions from packaging: Adults: Apply a small amount as a thin layer on the affected area twice daily, or use as directed by a physician. If no improvement is seen after 3 months of treatment, use of this product should be discontinued. Lightening effect of this product may not be noticeable when used on very dark skin. Children under 12 years of age: Do not use unless directed by a physician. Sun exposure should be limited by using a sunscreen agent, a sunblocking agent, or protective clothing to cover bleached skin, when using and after using this product to prevent darkening from reoccurring.
| score | data gap | concerns | |
| HYDROQUINONE (Active Ingredient) | 10 | 52% | Cancer, Developmental/reproductive toxicity, Violations, restrictions & warnings, Neurotoxicity, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards |
| BHT | 6 | 61% | Neurotoxicity, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards, Biochemical or cellular level changes |
| GLYCOLIC ACID | 4 | 70% | Violations, restrictions & warnings, Organ system toxicity (non-reproductive) |
| PROPYLENE GLYCOL | 4 | 60% | Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Enhanced skin absorption |
| SODIUM SULFITE | 3 | 87% | Neurotoxicity, Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| SODIUM BISULFITE | 3 | 75% | Neurotoxicity, Organ system toxicity (non-reproductive), Occupational hazards |
| CITRIC ACID | 3 | 72% | Violations, restrictions & warnings, Organ system toxicity (non-reproductive) |
| AMMONIUM HYDROXIDE | 2 | 81% | Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs) |
| TRISODIUM EDTA | 1 | 86% | Enhanced skin absorption |
| POLYQUATERNIUM-10 | 0 | 93% | none identified |
| WATER | 0 | 0% | innocuous |
*This table includes all possible cancer concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more in vitro tests non-mammalian cells show positive mutation results | AMMONIUM HYDROXIDE | |
| Limited evidence of carcinogenicity | HYDROQUINONE | |
| Cancer - not classifiable/not likely to be human carcinogen | BHT | |
| One or more in vitro tests on mammalian cells show positive mutation results | PROPYLENE GLYCOL, SODIUM SULFITE, SODIUM BISULFITE |
*This table includes all possible developmental/reproductive toxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Human nervous system toxicant - moderate evidence | HYDROQUINONE | |
| One or more animal studies show reproductive effects at moderate doses | PROPYLENE GLYCOL | |
| One or more animal studies show reproductive effects at high doses | GLYCOLIC ACID, BHT |
*This table includes all possible violations, restrictions & warnings concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications | HYDROQUINONE, PROPYLENE GLYCOL | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Use is restricted in Canadian cosmetics | HYDROQUINONE | |
| Determined safe for use in cosmetics, subject to concentration or use limitations - any | HYDROQUINONE, GLYCOLIC ACID | |
| Violation of industry recommendations - Restricted in cosmetics; use, concentration, or manufacturing restrictions - Safe for brief discontinuous use followed by thorough rinsing | products that are intended to be left on the skin | HYDROQUINONE |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Use is restricted in Canadian cosmetics | CITRIC ACID, GLYCOLIC ACID | |
| Violation of industry recommendations - Restricted in cosmetics; use, concentration, or manufacturing restrictions - Allowable pH limits | GLYCOLIC ACID |
*This table includes all possible neurotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show brain and nervous system effects at high doses | PROPYLENE GLYCOL | |
| One or more animal studies show brain and nervous system effects at moderate doses | GLYCOLIC ACID | |
| One or more animal studies show brain and nervous system effects at low doses | SODIUM BISULFITE, SODIUM SULFITE, BHT | |
| Strong evidence of human neurotoxicity | HYDROQUINONE |
*This table includes all possible endocrine disruption concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show endocrine system disruption at high doses | BHT, HYDROQUINONE |
*This table includes all possible allergies/immunotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Human immune system toxicant - moderate evidence | SODIUM SULFITE | |
| Limited evidence of skin and immune system toxicity | PROPYLENE GLYCOL | |
| Known human immune system toxicant | HYDROQUINONE, BHT |
*This table includes all possible persistence and bioaccumulation concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Not suspected to be bioaccumulative | AMMONIUM HYDROXIDE, SODIUM BISULFITE | |
| Not suspected to be persistent | HYDROQUINONE |
*This table includes all possible organ system toxicity (non-reproductive) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show blood effects at low doses | BHT | |
| One or more animal studies show broad systemic effects at moderate doses (low dose studies may be unavailable for this ingredient) | SODIUM BISULFITE, TRISODIUM EDTA, | |
| One or more animal studies show sense organ effects at moderate doses (low dose studies may be unavailable for this ingredient) | products for use around the eyes, mouth, or lips | PROPYLENE GLYCOL |
| One or more animal studies show sense organ effects at very low doses | products for use around the eyes, mouth, or lips | GLYCOLIC ACID, AMMONIUM HYDROXIDE, CITRIC ACID |
| Possible human immune system toxicant | SODIUM SULFITE | |
| Known human respiratory toxicant | HYDROQUINONE |
*This table includes all possible ecotoxicology concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Not suspected to be an environmental toxin | SODIUM BISULFITE | |
| Wildlife and environmental toxicity | HYDROQUINONE, AMMONIUM HYDROXIDE |
*This table includes all possible irritation (skin, eyes, or lungs) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show skin irritation at high doses | SODIUM BISULFITE, SODIUM SULFITE | |
| One or more animal studies show skin irritation at moderate doses | CITRIC ACID | |
| One or more animal studies show skin irritation at low doses | BHT | |
| One or more animal studies show skin irritation at very low doses | HYDROQUINONE | |
| Human skin irritant - moderate evidence | AMMONIUM HYDROXIDE | |
| Classified as skin irritant | PROPYLENE GLYCOL |
*This table includes all possible data gaps concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Safety assessment was based on related chemical | PROPYLENE GLYCOL | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | SODIUM BISULFITE, TRISODIUM EDTA, SODIUM SULFITE, POLYQUATERNIUM-10, BHT | |
| Not assessed for safety in cosmetics by industry panel | AMMONIUM HYDROXIDE, CITRIC ACID |
*This table includes all possible occupational hazards concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| No workplace limits set | GLYCOLIC ACID | |
| Allowed workplace exposures restricted to low doses | HYDROQUINONE, BHT, | |
| Allowed workplace exposures restricted to low doses | SODIUM BISULFITE |
*This table includes all possible biochemical or cellular level changes concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show biochemical changes at low doses where the human health implications are not yet well understood | BHT | |
| One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood | CITRIC ACID, SODIUM BISULFITE, PROPYLENE GLYCOL |
No items in basket.
Add this product
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
Stay informed with email updates on toxics in everyday products and how they can affect your health.
Find out more about the Campaign for Safe Cosmetics.